活性分子抑制剂-Amadis Chemical

图片	名称及描述
	(S)-4-(5-(5-溴-1-乙基-3-(3-羟基-2,2-二甲基丙基)-1H-吲哚-2-基)-6-(1-甲氧基乙基)吡啶-3-基)哌嗪-1-甲酸苄酯 Benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-yl)-6-(1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate A12593422865162-09-8 98%	Detail
	(S)-2-((S)-7-(tert-Butoxycarbonyl)-2,7-diazaspiro[4.4]nonan-2-yl)-2-cyclopentylacetic acid (S)-2-((S)-7-(tert-Butoxycarbonyl)-2,7-diazaspiro[4.4]nonan-2-yl)-2-cyclopentylacetic acid A12593432865128-45-4 98%	Detail
	(14S,18S)-4-Amino-2-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-1-ethyl-18,19,20,21-tetrahydro-25,25-dimethyl-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indole-15,22-dione (14S,18S)-4-Amino-2-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-1-ethyl-18,19,20,21-tetrahydro-25,25-dimethyl-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indole-15,22-dione A12593442865128-15-8 98%	Detail
	N-[(14S,18S)-1-乙基-18,19,20,21-四氢-2-[2-[(1S)-1-甲氧基乙基]-5-(1-哌嗪基)-3-吡啶基]-25,25-二甲基-15,22-二氧代-17H-5,3-([4,2]-endo-噻唑丙烷并[1,3]-endo-哒嗪甲桥氧基丙烷)-1H-吲哚-14-基]氨基甲酸叔丁酯 tert-Butyl N-[(14S,18S)-1-ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]carbamate A12593452865127-16-6 98%	Detail
	2864383-31-3 2864383-31-3 A12593472864383-31-3	Detail
	3-(1H-苯并[d]咪唑-2-基)-5-(3-(苄氧基)苯基)-1H-吲唑 Xist inhibitor X1 A12593482863686-82-0 98%	Detail
	4-((4-(1-(3-(氰甲基)-1-(乙基磺酰基)氮杂环丁烷-3-基)-1H-吡唑-4-基)-7H-吡咯并[2,3-d]嘧啶-2-基)氨基)-N-(2-(4-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-5-基)哌嗪-1-基)乙基)苯甲酰胺 SJ1008030 A12593512863634-96-0 98%	Detail
	(E)-4,6-二氧代辛-2-烯二酸 (E)-4,6-Dioxooct-2-enedioic acid A125935228613-33-4 98%	Detail
	ITK degrader 2 ITK degrader 2 A12593542858738-65-3 98%	Detail
	5-(4-((1-(4-((5-溴-4-((4-环丙基-2-(二甲基磷酰基)苯基)氨基)嘧啶-2-基)氨基)-5-甲氧基-2-(1-甲基-1H-吡唑-4-基)苯基)哌啶-4-基)甲基)哌嗪-1-基)-2-(2,6-二氧代哌啶-3-基)异吲哚啉-1,3-二酮 5-(4-((1-(4-((5-Bromo-4-((4-cyclopropyl-2-(dimethylphosphoryl)phenyl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione A12593532861227-35-0 98%	Detail
	PF-6870961 PF-6870961 A12593552857112-06-0 98%	Detail
	CB014871627 CB014871627 A12593562857047-24-4 98%	Detail
	Menin-MLL inhibitor-22 Menin-MLL inhibitor-22 A12593572851841-61-5 98%	Detail
	PROTAC eDHFR Degrader-1 PROTAC eDHFR Degrader-1 A12593582849442-92-6 98%	Detail
	RXP03 RXP03 A1259360284667-65-8 98%	Detail
	7-(8-甲基萘-1-基)-4-((R)-2-甲基哌嗪-1-基)-2-(((S)-1-甲基吡咯烷-2-基)甲氧基)-5,6,7,8-四氢吡啶并[3,4-d]嘧啶 TH-Z816 A12593592847881-42-7 98%	Detail
	QR-6401 QR-6401 A12593612845096-18-4 98%	Detail
	CCG-977 CCG-977 A1259362284487-50-9 98%	Detail
	Ruxoprubart Ruxoprubart A12593632842046-67-5 98%	Detail
	N-((1H-I吲唑-7-基)甲基)-2-乙氧基-3'-氟-N-甲基-[1,1'-联苯]-4-甲酰胺 BAL-0028 A12593642842012-69-3 98%	Detail